{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:43:42Z","timestamp":1761597822065,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30901204"],"award-info":[{"award-number":["30901204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.05.060","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T20:04:26Z","timestamp":1496261066000},"page":"3709-3717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intradermal injection of a fractional dose of an inactivated HFMD vaccine elicits similar protective immunity to intramuscular inoculation of a full dose of an Al(OH)3-adjuvanted vaccine"],"prefix":"10.1016","volume":"35","author":[{"given":"Min","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueqiang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaozhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baodong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongpeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songcai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.05.060_b0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00430-016-0465-y","article-title":"Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy","author":"Aswathyraj","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.05.060_b0010","first-page":"43","article-title":"Study of the epidemiology and etiological characteristics of hand, foot, and mouth disease in Suzhou City, East China, 2011\u20132014","volume":"2016","author":"Xia","year":"1933","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2017.05.060_b0015","doi-asserted-by":"crossref","unstructured":"Yao X, Bian LL, Lu WW, Li JX, Mao QY, Wang YP, et al. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014. Hum Vaccine Immunother; 2016\/10\/21 ed: 0.","DOI":"10.1080\/21645515.2016.1236879"},{"key":"10.1016\/j.vaccine.2017.05.060_b0020","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated Enterovirus 71 and Coxsackievirus A16 elicits balanced protective immunity against both viruses","author":"Cai","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.060_b0025","doi-asserted-by":"crossref","first-page":"e37206","DOI":"10.1371\/journal.pone.0037206","article-title":"Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants","author":"Zhu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.060_b0030","doi-asserted-by":"crossref","unstructured":"Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, et al. An inactivated Enterovirus 71 vaccine in healthy children. N Engl J Med: 829\u201337.","DOI":"10.1056\/NEJMoa1303224"},{"key":"10.1016\/j.vaccine.2017.05.060_b0035","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant Enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.05.060_b0040","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2012.03.010","article-title":"Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, phase I clinical trial","author":"Li","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.060_b0045","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa043540","article-title":"Dose sparing with intradermal injection of influenza vaccine","author":"Kenney","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.05.060_b0050","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1016\/j.vaccine.2015.06.071","article-title":"Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: association between injection quality and immunogenicity","author":"Resik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.060_b0055","doi-asserted-by":"crossref","unstructured":"Resik S, Tejeda A, Sutter RW, Diaz M, Sarmiento L, Alema N, et al. Priming after a fractional dose of inactivated poliovirus vaccine. N Engl J Med: 416\u201324.","DOI":"10.1056\/NEJMoa1202541"},{"key":"10.1016\/j.vaccine.2017.05.060_b0060","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4161\/hv.6.12.12982","article-title":"Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys","author":"Dong","year":"2010","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.060_b0065","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4161\/hv.28083","article-title":"Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line","author":"Yang","year":"2014","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2017.05.060_b0070","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.3390\/v7072803","article-title":"Optimization and characterization of candidate strain for Coxsackievirus A16 inactivated vaccine","author":"Li","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2017.05.060_b0075","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.vaccine.2013.03.007","article-title":"Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection","author":"Cai","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.05.060_b0080","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1128\/JVI.00902-12","article-title":"A neonatal mouse model of Coxsackievirus A16 for vaccine evaluation","author":"Mao","year":"2012","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2017.05.060_b0085","doi-asserted-by":"crossref","unstructured":"Sun S, Jiang L, Liang Z, Mao Q, Su W, Zhang H, et al. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice. Hum Vaccine Immunother: 2885-95.","DOI":"10.4161\/hv.29823"},{"key":"10.1016\/j.vaccine.2017.05.060_b0090","doi-asserted-by":"crossref","first-page":"e20005","DOI":"10.1371\/journal.pone.0020005","article-title":"Purification and characterization of Enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.060_b0095","first-page":"67","article-title":"Clinically isolated Enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model","author":"Xu","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.vaccine.2017.05.060_b0100","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1016\/j.vaccine.2011.06.044","article-title":"Immunoprotection elicited by an Enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys","author":"Dong","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.05.060_b0105","doi-asserted-by":"crossref","first-page":"e1001958","DOI":"10.1371\/journal.pmed.1001958","article-title":"Hand, foot, and mouth disease in China: modeling epidemic dynamics of enterovirus serotypes and implications for vaccination","author":"Takahashi","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2017.05.060_b0110","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00705-010-0722-0","article-title":"Emergence of Enterovirus 71 \u201cdouble-recombinant\u201d strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71","author":"Yip","year":"2010","journal-title":"Arch Virol."},{"key":"10.1016\/j.vaccine.2017.05.060_b0115","doi-asserted-by":"crossref","first-page":"e79783","DOI":"10.1371\/journal.pone.0079783","article-title":"Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers","author":"Chou","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.vaccine.2017.05.060_b0120","doi-asserted-by":"crossref","first-page":"e49973","DOI":"10.1371\/journal.pone.0049973","article-title":"Immunological and biochemical characterization of coxsackie virus A16 viral particles","author":"Chong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.060_b0125","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.4161\/hv.25639","article-title":"Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1\/EV71\/JEV","author":"Lin","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.05.060_b0130","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1080\/21645515.2015.1011975","article-title":"The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals","author":"Mao","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.05.060_b0135","doi-asserted-by":"crossref","unstructured":"Amorij JP, Hinrichs WLj, Frijlink HW, Wilschut JC, Huckriede A. Needle-free influenza vaccination. Lancet Infect Dis: 699-711.","DOI":"10.1016\/S1473-3099(10)70157-2"},{"key":"10.1016\/j.vaccine.2017.05.060_b0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/17434440.3.5.565","article-title":"Needle-free liquid jet injections: mechanisms and applications","author":"Baxter","year":"2006","journal-title":"Expert Rev Med Dev"},{"key":"10.1016\/j.vaccine.2017.05.060_b0145","first-page":"523","article-title":"Devices for intradermal vaccination","author":"Kis","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.060_b0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2016.10.019","article-title":"Transcutaneous immunization via rapidly dissolvable microneedles protects against hand-foot-and-mouth disease caused by Enterovirus 71","author":"Zhu","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.05.060_b0155","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/lsm.22517","article-title":"Investigating skin penetration depth and shape following needle-free injection at different pressures: a cadaveric study","author":"Seok","year":"2016","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.vaccine.2017.05.060_b0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tvjl.2013.06.019","article-title":"A study of the effectiveness of a needle-free injection device compared with a needle and syringe used to vaccinate calves against bovine viral diarrhea and infectious bovine rhinotracheitis viruses","author":"Rey","year":"2013","journal-title":"Vet J."},{"key":"10.1016\/j.vaccine.2017.05.060_b0165","first-page":"307","article-title":"Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba","author":"Resik","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.060_b0170","unstructured":"Ploemen IH, Hirschberg HJ, Kraan H, Zeltner A, van Kuijk S, Lankveld DP, et al. Minipigs as an animal model for dermal vaccine delivery. Comp Med: 50\u20134."},{"key":"10.1016\/j.vaccine.2017.05.060_b0175","doi-asserted-by":"crossref","unstructured":"Gan ZK, Jin H, Li JX, Yao XJ, Zhou Y, Zhang XF, et al. Disease burden of Enterovirus 71 in rural central China: A community-based survey. Hum Vaccine Immunother: 2400-5.","DOI":"10.1080\/21645515.2015.1059980"},{"key":"10.1016\/j.vaccine.2017.05.060_b0180","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1016\/j.vaccine.2010.09.065","article-title":"Forecasting the economic value of an Enterovirus 71 (EV71) vaccine","author":"Lee","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.060_b0185","first-page":"138","article-title":"Socioeconomic burden of hand, foot and mouth disease in children in Shanghai, China","author":"Wang","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.05.060_b0190","doi-asserted-by":"crossref","first-page":"e1001975","DOI":"10.1371\/journal.pmed.1001975","article-title":"Routine pediatric Enterovirus 71 vaccination in China: a cost-effectiveness analysis","author":"Wu","year":"2016","journal-title":"PLoS Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T02:38:00Z","timestamp":1655692680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17307089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":38,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17307089"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradermal injection of a fractional dose of an inactivated HFMD vaccine elicits similar protective immunity to intramuscular inoculation of a full dose of an Al(OH)3-adjuvanted vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}